Details for 2019732174
Up to date per 02.04.2026
Actions
Details for 2019732174
Granted/Registered
European Patent
23.09.2020 A
31.03.2021 B1
30.05.2018
US
201862678061 P
C07K 16/28 20060101AFI20191206BHEP
Owner
AbbVie Stemcentrx LLC1 North Waukegan Road North Chicago, IL 60064-6400US
Representative
Representative
Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT
Inventor
LIU, David495 Loma Vista Terrace Pacifica, California 94044US
GAVRILYUK, Julia3525 Del Mar Heights Road, 1855 San Diego,CA 92130US
SCHAMMEL, Alexander25 Glendale Street, Apt. 3 San Francisco, California 94114US
Information about Fees